Ultrasound-guided Erector Spinae Plane Block Versus Local Wound Infiltration in Breast Conservative Surgery

December 10, 2025 updated by: Tasneem Hassan El-Tohamy, Cairo University

Ultrasound-guided Erector Spinae Plane Block Versus Local Wound Infiltration in Breast Conservative Surgery, Randomized Double Blinded Comparative Study

Abstract

Background:

Postoperative pain management is a crucial component of patient care following breast conservative surgery. This study compares the efficacy of ultrasound-guided Erector Spinae Plane Block (ESPB) and Local Wound Infiltration (LWI) in managing acute postoperative pain in these surgeries.

Objectives:

This randomized, double-blinded, controlled clinical trial aims to compare the analgesic efficacy and safety of ultrasound-guided ESPB and LWI in patients undergoing breast conservative surgery.

Patients and methods:

Adult female patients (aged 18-75, ASA II) scheduled for breast conservative surgery were randomly assigned to either the ESPB or LWI group. The primary outcome was total morphine consumption in the first 24 hours postoperatively. Secondary outcomes included; intraoperative fentanyl consumption, hemodynamic parameters (mean arterial blood pressure and heart rate), time of first rescue analgesia, postoperative pain scores, the incidence of postoperative nausea and vomiting (PONV) and patient satisfaction. Complications such as local anesthetic toxicity and respiratory depression were also assessed.

Key Words:

Erector Spinae Plane Block (ESPB), Local wound infiltration, Postoperative analgesia, Breast conservative surgery

Study Overview

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • National Cancer Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age from 18 to 75 years.
  • Genders eligible for study: females.
  • ASA II.
  • Patients scheduled for breast conservative surgery.
  • Ability to provide informed consent or, if unable, consent obtained from a legal representative

Exclusion Criteria:

  • Patient refusal.
  • Inability to provide informed consent.
  • ASA III-IV.
  • Known sensitivity or contraindication to drug used in the study (local anesthetics, opioids).
  • Pregnant or lactating women.
  • History of psychological disorders and/or chronic pain. 25
  • Contraindication to regional anesthesia e.g. local sepsis, pre- existing peripheral neuropathies and coagulopathy.
  • Severe respiratory or cardiac disorders.
  • Advanced liver or kidney disease.
  • Male patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1 (experimental group): will receive US guided ESPB
Typical ESPB
Active Comparator: Group 2 (controlled group): will receive local wound infiltration
Preemptive Local Wound Infiltration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total amount of morphine consumed postoperatively for 24 hours.
Time Frame: up to 24 hours postoperative
Total amount of morphine consumed postoperatively for 24 hours (mg/kg)
up to 24 hours postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total amount of fentanyl consumed intraoperatively
Time Frame: Perioperative/Periprocedural
Total amount of fentanyl consumed intraoperatively (mic/kg)
Perioperative/Periprocedural
Hemodynamics: heart rate intraoperatively at 30-minute intervals in comparison to baseline readings.
Time Frame: Perioperative/Periprocedural
Hemodynamics: heart rate intraoperatively at 30-minute intervals in comparison to baseline readings (beats/min)
Perioperative/Periprocedural
Hemodynamics: mean arterial blood pressure intraoperatively at 30-minute intervals in comparison to baseline readings.
Time Frame: Perioperative/Periprocedural
Hemodynamics: mean arterial blood pressure intraoperatively at 30-minute intervals in comparison to baseline readings (mmHg)
Perioperative/Periprocedural
Heart rate at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
Time Frame: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
Heart rate at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively (beats/min)
at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
Mean arterial blood pressure at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
Time Frame: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
Mean arterial blood pressure at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively (mmHg)
at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
The visual analog scale (VAS) (at rest and during movement) at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
Time Frame: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
The visual analog scale (VAS) is a pain rating scale first used by Hayes and Patterson in 1921. Scores are based on self-reported measures of symptoms that are recorded with a single handwritten mark placed at one point along the length of a 10-cm line that represents a continuum between the two ends of the scale "no pain" on the left end (0 cm) of the scale and the "worst pain" on the right end of the scale (10cm)
at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.
Postoperative nausea and vomiting (PONV) as side effects of morphine.
Time Frame: up to 24 hours postoperative
Postoperative nausea and vomiting (PONV) will be rated on a four-point verbal scale; (none =no nausea, mild =nausea but no vomiting, moderate=vomiting one attack, severe=vomiting >one attack).
up to 24 hours postoperative
Time of first rescue analgesia intra-operative (Fentanyl)
Time Frame: up to 24 hours postoperative
Time of first rescue analgesia (min)
up to 24 hours postoperative
Time of first rescue analgesia post-operative (Morphine)
Time Frame: up to 24 hours postoperative
Time of first rescue analgesia (hrs.)
up to 24 hours postoperative
Complications such as local anaesthetic systemic toxicity, pneumothorax and arterial puncture. (US check postoperative).
Time Frame: up to 24 hours postoperative
Complications such as local anaesthetic systemic toxicity, pneumothorax and arterial puncture. (US check postoperative).
up to 24 hours postoperative
Morphine related complications such as respiratory depression, urine retention or pruritic
Time Frame: up to 24 hours postoperative
Morphine related complications such as respiratory depression, urine retention or pruritic
up to 24 hours postoperative
Patient satisfaction the patient will be classified in this group into satisfied or not.
Time Frame: up to 24 hours postoperative
Patient satisfaction the patient will be classified in this group into satisfied or not.
up to 24 hours postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 21, 2024

Primary Completion (Actual)

December 23, 2024

Study Completion (Actual)

December 23, 2024

Study Registration Dates

First Submitted

November 13, 2025

First Submitted That Met QC Criteria

December 10, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 10, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain Management

Clinical Trials on Erector Spinae Plane Block

Subscribe